But since we all kind of draw from the same body of technology, if you will, what is it that really makes the US special in this case?

So one of the findings that we have is that if you look at healthcare as a share of GDP in the US compared to other OECD countries, in the past decade or so, it's been the only time when healthcare in the United States as a share of GDP has grown more slowly than the composite of other OECD countries.

And that fact was particularly striking for us, and it showed that what's happened in the United States over the past fifteen years or so has happened, you know, even more so here than elsewhere.

It's true that healthcare slowed a bit in other countries as well, so it's completely possible that many of the technological advances that have happened here that have led to slower growth have also happened elsewhere.

The key cases that we look at are cardiovascular disease and the shift from inpatient to outpatient surgery.

And what's fascinating about both of these cases is that while in the past technology has been a leading driver of growth in healthcare spending as we've been able to treat more conditions and solve more problems, what's fascinating about these cases is that we're actually able to do oftentimes better, even in the case of cardiovascular disease, a lot cheaper.

Lev, do you wanna jump in here?

Sure.